Skip to content

The cystic fibrosis home sputum induction trial

The cystic fibrosis home sputum induction trial - self-management for better microbiology surveillance

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86523335
Enrollment
100
Registered
2022-10-24
Start date
2022-09-09
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic fibrosis Nutritional, Metabolic, Endocrine

Interventions

Home sputum induction, home saliva and clinic saliva sampling for comparative microbiology analysis and scientific microbiota analysis compared to clinic gold standard cough swab and sputum induction.

Sponsors

Cardiff and Vale University Health Board
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Cystic fibrosis 2. Using hypertonic saline as part of an established physiotherapy regimen at home

Exclusion criteria

Exclusion criteria: Unable to expectorate spontaneously

Design outcomes

Primary

MeasureTime frame
Pathogen detection rate of matched home sputum induction and home saliva versus Gold standard clinic cough swab measured using microbiology analysis as per CF Trust Microbiology Guidelines at a single time point

Secondary

MeasureTime frame
Pathogen detection rate of home sputum induction and home saliva versus clinic sputum induction and saliva samples measured using microbiology analysis as per CF Trust Microbiology Guidelines at a single time point

Countries

United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 1, 2026